Page last updated: 2024-08-24

1,7-phenanthroline and formazans

1,7-phenanthroline has been researched along with formazans in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoyer, PE; Moller, M1
Ahmad, A; Farhan Asad, S; Hadi, SM; Singh, S1
Gao, HW; Wang, HY; Xia, SQ; Zhang, SY; Zhang, YL1
Berger, W; Chiba, P; Dornetshuber, R; Elbling, L; Heffeter, P; Jakupec, MA; Keppler, BK; Körner, W; Micksche, M; Pirker, C; Sutterlüty, H1

Other Studies

4 other study(ies) available for 1,7-phenanthroline and formazans

ArticleYear
Histochemistry of 11-beta-hydroxysteroid dehydrogenase in rat submandibular gland. Effect of cortisol stimulation.
    The Histochemical journal, 1977, Volume: 9, Issue:5

    Topics: Alcohol Oxidoreductases; Alkaline Phosphatase; Androstenedione; Animals; Dimethyl Sulfoxide; Female; Formamides; Formazans; Hydrocortisone; Hydroxysteroid Dehydrogenases; NAD; NADP; Nitroblue Tetrazolium; Oxidoreductases; Phenanthrolines; Rats; Submandibular Gland; Tetrazolium Salts

1977
DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation.
    Cancer letters, 2000, Jun-01, Volume: 154, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Bacteriophage lambda; Cattle; Copper; DNA; DNA Damage; Dose-Response Relationship, Drug; Endoribonucleases; Formazans; Free Radical Scavengers; Ions; Neoplasms; Phenanthrolines; Reactive Oxygen Species; Resveratrol; Spectrophotometry; Stilbenes; Thymus Gland; Time Factors; Ultraviolet Rays

2000
Application of light-absorption ratio variation approach as an optimum spectrophotometry to determination of Mn(II) in ng ml(-1) level using a competitive replacement complexation.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2005, Jan-14, Volume: 61, Issue:3

    Topics: Binding, Competitive; Formazans; Manganese; Phenanthrolines; Water; Zinc

2005
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
    Biochemical pharmacology, 2007, Jun-15, Volume: 73, Issue:12

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Formazans; HL-60 Cells; Humans; Lanthanum; Lung Neoplasms; Molecular Structure; Neoplasm Proteins; Organic Anion Transporters; Organometallic Compounds; Phenanthrolines; Sensitivity and Specificity; Tetrazolium Salts

2007